Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) has cleared Premier® HpSA® FLEX™ for the diagnosis of H. pylori in both preserved and unpreserved stools. Premier HpSA Flex joins the extensive Meridian H. pylori portfolio of products that includes BreathID® (urea breath test for H. pylori), Curian® HpSA (fluorescent immuno analyzer antigen test), and ImmunoCard® Stat! HpSA (rapid colorimetric antigen test).

Meridian strives to continuously improve existing products. The Premier HpSA FLEX workflow improvement recently cleared by FDA allows clinicians to use preserved stools in Cary-Blair and C&S in addition to fresh or frozen unpreserved samples. Meridian’s Premier HpSA FLEX test is a non-invasive enzyme immunoassay used to qualitatively detect Helicobacter pylori (H. pylori) specific antigens in fresh, frozen, or preserved human fecal specimens. Helicobacter pylori infection is linked to several significant upper gastrointestinal (GI) conditions, including chronic gastritis, peptic ulcer disease, and gastric cancer.

“Meridian is committed to developing the industry’s broadest range of highly accurate Gastrointestinal diagnostic solutions enabling clinicians to use the sample types and testing platforms required in today’s ever-evolving healthcare landscape,”

Tony Serafini-Lamanna, President of Meridian Bioscience Diagnostics.

Tony adds, “H. pylori is found in the stomach lining of 1 in 3 people1 and, if left untreated, can lead to gastric cancer. However, once diagnosed, an H. pylori infection can be easily treated with antibiotics. That is why we continue to develop highly accurate non-invasive, patient-friendly H. pylori testing methods to help clinicians get patients on the road to wellness as fast and safely as possible.”

You can learn more about Meridian’s diagnostic testing solutions by visiting their exhibit booth (4039) during this year’s AACC conference held in July in Anaheim, California. You can schedule a one-on-one meeting with a Meridian representative by emailing [email protected].

To learn more about H. pylori and Meridian’s testing solutions, please visit www.meridianbioscience.com/hpylori.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meridian Bioscience, Inc.. (2023, September 18). Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex. News-Medical. Retrieved on May 23, 2024 from https://www.news-medical.net/news/20230918/Meridian-Bioscience-continues-expansion-of-H-pylori-diagnostic-testing-solutions-with-FDA-clearance-of-premier-HpSA-flex.aspx.

  • MLA

    Meridian Bioscience, Inc.. "Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex". News-Medical. 23 May 2024. <https://www.news-medical.net/news/20230918/Meridian-Bioscience-continues-expansion-of-H-pylori-diagnostic-testing-solutions-with-FDA-clearance-of-premier-HpSA-flex.aspx>.

  • Chicago

    Meridian Bioscience, Inc.. "Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex". News-Medical. https://www.news-medical.net/news/20230918/Meridian-Bioscience-continues-expansion-of-H-pylori-diagnostic-testing-solutions-with-FDA-clearance-of-premier-HpSA-flex.aspx. (accessed May 23, 2024).

  • Harvard

    Meridian Bioscience, Inc.. 2023. Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex. News-Medical, viewed 23 May 2024, https://www.news-medical.net/news/20230918/Meridian-Bioscience-continues-expansion-of-H-pylori-diagnostic-testing-solutions-with-FDA-clearance-of-premier-HpSA-flex.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.